149 related articles for article (PubMed ID: 9619633)
21. Properties of enzymatically isolated skeletal fibres from mice with muscular dystrophy.
Head SI; Stephenson DG; Williams DA
J Physiol; 1990 Mar; 422():351-67. PubMed ID: 2352184
[TBL] [Abstract][Full Text] [Related]
22. Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue.
Harcourt LJ; Schertzer JD; Ryall JG; Lynch GS
Neuromuscul Disord; 2007 Jan; 17(1):47-55. PubMed ID: 17134898
[TBL] [Abstract][Full Text] [Related]
23. Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery.
Py G; Ramonatxo C; Sirvent P; Sanchez AM; Philippe AG; Douillard A; Galbès O; Lionne C; Bonnieu A; Chopard A; Cazorla O; Lacampagne A; Candau RB
J Physiol; 2015 Apr; 593(8):2071-84. PubMed ID: 25656230
[TBL] [Abstract][Full Text] [Related]
24. Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.
Ryall JG; Gregorevic P; Plant DR; Sillence MN; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2002 Dec; 283(6):R1386-94. PubMed ID: 12388476
[TBL] [Abstract][Full Text] [Related]
25. Myosin isoenzymes in fast-twitch and slow-twitch muscles of normal and dystrophic mice.
Fitzsimons RB; Hoh JF
J Physiol; 1983 Oct; 343():539-50. PubMed ID: 6227740
[TBL] [Abstract][Full Text] [Related]
26. Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice.
Dupont-Versteegden EE
J Appl Physiol (1985); 1996 Mar; 80(3):734-41. PubMed ID: 8964730
[TBL] [Abstract][Full Text] [Related]
27. Improvement of dy/dy dystrophic diaphragm by 3,4-diaminopyridine.
van Lunteren E; Moyer M
Muscle Nerve; 2002 Jul; 26(1):71-8. PubMed ID: 12115951
[TBL] [Abstract][Full Text] [Related]
28. Clenbuterol has a greater influence on untrained than on previously trained skeletal muscle in rats.
Murphy RJ; Béliveau L; Seburn KL; Gardiner PF
Eur J Appl Physiol Occup Physiol; 1996; 73(3-4):304-10. PubMed ID: 8781861
[TBL] [Abstract][Full Text] [Related]
29. Metabolic and physiologic characteristics of skeletal muscle determine its response to clenbuterol treatment.
Sundal S; Katoch SS; Sharma S
Indian J Biochem Biophys; 2006 Jun; 43(3):160-6. PubMed ID: 16967905
[TBL] [Abstract][Full Text] [Related]
30. Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers.
Lynch GS; Hayes A; Campbell SP; Williams DA
J Appl Physiol (1985); 1996 Oct; 81(4):1610-8. PubMed ID: 8904577
[TBL] [Abstract][Full Text] [Related]
31. Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol.
Gregorevic P; Williams DA; Lynch GS
Muscle Nerve; 2002 Feb; 25(2):194-201. PubMed ID: 11870686
[TBL] [Abstract][Full Text] [Related]
32. Isotonic fatigue in laminin alpha2-deficient dy/dy dystrophic mouse diaphragm.
Pollarine J; Moyer M; Van Lunteren E
Muscle Nerve; 2007 Nov; 36(5):672-8. PubMed ID: 17661374
[TBL] [Abstract][Full Text] [Related]
33. Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice.
Williams DA; Head SI; Lynch GS; Stephenson DG
J Physiol; 1993 Jan; 460():51-67. PubMed ID: 8487206
[TBL] [Abstract][Full Text] [Related]
34. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats.
Chen KD; Alway SE
J Appl Physiol (1985); 2000 Aug; 89(2):606-12. PubMed ID: 10926644
[TBL] [Abstract][Full Text] [Related]
35. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle.
Dodd SL; Powers SK; Vrabas IS; Criswell D; Stetson S; Hussain R
Med Sci Sports Exerc; 1996 Jun; 28(6):669-76. PubMed ID: 8784754
[TBL] [Abstract][Full Text] [Related]
36. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
37. Calcium and strontium activation of single skinned muscle fibres of normal and dystrophic mice.
Fink RH; Stephenson DG; Williams DA
J Physiol; 1986 Apr; 373():513-25. PubMed ID: 3746681
[TBL] [Abstract][Full Text] [Related]
38. Exercise effect on contractile properties of skeletal muscle in mouse muscular dystrophy.
Taylor RG; Fowler WM; Doerr L
Arch Phys Med Rehabil; 1976 Apr; 57(4):174-80. PubMed ID: 1267593
[TBL] [Abstract][Full Text] [Related]
39. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
40. Inotrophic effects of the K(+) channel blocker TEA on dystrophic (mdx and dy/dy) mouse diaphragm.
van Lunteren E; Manubay P
Respir Physiol; 2001 Apr; 125(3):249-54. PubMed ID: 11282391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
